Live Help

IMITREX-100(Sumatriptan succinate-100)

Sumatriptan succinate-100

International Name
- Imitrex 100
Manufacturer
- Centurion Laboratories
Contains
- IMITREX-100(Sumatriptan succinate-100)
Packing
- 1
Strength
- 100mg
Form
- Tablets

Get A Quote
Share: 0
Category: .

Imitrex; INDICATIONS Sumatriptan succinate tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. Sumatriptan succinate tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine.

Safety and effectiveness of sumatriptan succinate tablets have not been established for cluster headache, which is present in an older, predominantly male population. DOSAGE AND ADMINISTRATION In controlled clinical trials, single doses of 25, 50, or 100 mg of sumatriptan succinate tablets were effective for the acute treatment of migraine in adults. There is evidence that doses of 50 and 100 mg may provide a greater effect than 25 mg (see CLINICAL STUDIES).

There is also evidence that doses of 100 mg do not provide a greater effect than 50 mg. Individuals may vary in response to doses of sumatriptan succinate tablets. The choice of dose should therefore be made on an individual basis, weighing the possible benefit of a higher dose with the potential for a greater risk of adverse events. If the headache returns or the patient has a partial response to the initial dose, the dose may be repeated after 2 hours, not to exceed a total daily dose of 200 mg. If a headache returns following an initial treatment with sumatriptan succinate injection, additional single sumatriptan succinate tablets (up to 100 mg/day) may be given with an interval of at least 2 hours between tablet doses.

The safety of treating an average of more than 4 headaches in a 30-day period has not been established. Because of the potential of MAO-A inhibitors to cause unpredictable elevations in the bioavailability of oral sumatriptan, their combined use is contraindicated (see CONTRAINDICATIONS). Hepatic disease/functional impairment may also cause unpredictable elevations in the bioavailability of orally administered sumatriptan.

Enquiry about IMITREX-100(Sumatriptan succinate-100)

Your Name (required)

Your Email (required)

Confirm Email (required)

Your Contact)

Your Country (required)

Subject

Your Message

Security Code
captcha